Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04719013 · ClinicalTrials.gov registry record · NA
Treatment With the Evoke System for Facial and Submental Laxity
A NA study, sponsored by InMode MD.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT04719013 is a NA study that has completed, run by InMode MD. The registered enrollment target is 85 participants.
The verdict
NCT04719013, a NA study, has completed, sponsored by InMode MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The aim of the study is to evaluate the efficacy, patient comfort, and patient satisfaction after Evoke treatment for face and submental area
Interventions
- DEVICE Evoke radiofrequency device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2022-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04719013
The ClinicalTrials.gov registry entry for NCT04719013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Evoke radiofrequency device is the first listed.
NCT04719013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04719013 about?
NCT04719013 is a clinical study titled "Treatment With the Evoke System for Facial and Submental Laxity". The aim of the study is to evaluate the efficacy, patient comfort, and patient satisfaction after Evoke treatment for face and submental area
What is the current status of trial NCT04719013?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2020-12-01. Estimated completion is 2022-07-20.
What interventions are being tested in trial NCT04719013?
The interventions under investigation include: Evoke radiofrequency device (DEVICE).
Who is sponsoring clinical trial NCT04719013?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.